Adventa Bhd (XKLS:7191) ROCE %: -6.72% (As of Mar. 2026)

What is Adventa Bhd ROCE %?

Adventa Bhd XKLS:7191 36 ROCE % is -6.72% as of Mar. 2026. GuruFocus rates XKLS:7191 with a GF Score™ of 36/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Adventa Bhd's annualized ROCE % for the quarter that ended in Mar. 2026 was -6.72%.

Adventa Bhd (XKLS:7191) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Adventa Bhd ROCE % Related Terms

Adventa Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for Adventa Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adventa Bhd ROCE % Chart

Adventa Bhd Annual Data

Trend

Oct15

Oct16

Oct17

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

12.49

-7.01

-11.98

2.69

-4.00

Adventa Bhd Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															1.55	2.33	1.23	-18.27	-6.72

36GF Score

Adventa Bhd XKLS:7191

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Adventa Bhd ROCE % Calculation

Adventa Bhd's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-3.967	/	( ( (112.444 - 14.482)	+	(111.142 - 10.777) )	/ 2 )
	=	-3.967	/	( (97.962	+	100.365)	/ 2 )
	=	-3.967	/	99.1635
	=	-4.00 %

Adventa Bhd's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-6.644	/	( ( (111.142 - 10.777)	+	(103.974 - 6.546) )	/ 2 )
	=	-6.644	/	( ( 100.365	+	97.428 )	/ 2 )
	=	-6.644	/	98.8965
	=	-6.72 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -6.72% mean?

Adventa Bhd (XKLS:7191) has a ROCE % of -6.72% as of Mar. 2026.

Is Adventa Bhd's ROCE % too high?

Adventa Bhd's current ROCE % is -6.72%. Overall, Adventa Bhd has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Adventa Bhd's ROCE % compare to ISRG and BDX?

Adventa Bhd's ROCE % of -6.72% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adventa Bhd's current ROCE % is -6.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Adventa Bhd stock overvalued right now?

Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 45.8% below its estimated fair value. The current ROCE % is -6.72%. Adventa Bhd's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current ROCE % is -6.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adventa Bhd (XKLS:7191) Overvalued in 2026?

Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued. The current stock price of RM0.13 is trading 45.8% below its estimated GF Value™ of RM0.24. GuruFocus considers Adventa Bhd to be Possible Value Trap.

Key valuation signals for XKLS:7191:

ROCE %: -6.72%
GF Value™: RM0.24 vs. price of RM0.13 (45.8% below fair value)
GF Score™: 36/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adventa Bhd Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XKLS:0163 XKLS:0094 XKLS:0182 XKLS:5079 XKLS:9113 ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM XSWX:STMN XTER:SRT OCSE:COLO B NZSE:FPH SOLV

Address No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050

Website https://www.adventa.com.my

Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.

36GF Score

Get the complete analysis for XKLS:7191

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.13

Price

RM0.24

GF Value

View XKLS:7191 Analysis

See ROCE % data for all stocks →